Key result
Higher mitochondrial DNA copy number is linked to ~26% lower risk of incident HF.
Why the study?
The association between mitochondrial DNA-copy number and incident heart failure in the general population was unclear.
Is higher mitochondrial DNA copy number associated with a reduced risk of incident heart failure in a general population free of HF at baseline?
Cohort (n=10,802)
Yes
Is higher mitochondrial DNA copy number associated with a reduced risk of incident heart failure in a general population free of HF at baseline?
Hazard Ratio: 0.74 (95% CI 0.65–0.85)
p-value: p=<0.001
Higher mitochondrial DNA copy number is independently associated with a lower risk of incident heart failure, suggesting mitochondrial dysfunction may be an early marker of HF susceptibility.
Should not yet inform HF risk stratification in practice; hypothesis-generating for mitochondrial biomarkers in HF susceptibility.
Background The association between mitochondrial DNA-copy number (mtDNA-CN) and incident heart failure (HF) in the general population is unclear. Methods We examined the association between mtDNA-CN and the risk of incident HF among 10,802 participants free of HF at baseline from the Atherosclerosis Risk in Communities (ARIC) study, a large bi-racial population-based cohort. mtDNA-CN was estimated using probe intensities on the Affymetrix Genome-Wide Human single nucleotide polymorphisms Array 6.0. Incident HF events were identified through hospital discharge codes from 1987 until 2005 and through adjudication by the ARIC HF Classification Committee since 2005. Results During a median follow-up of 23.1 years, there were 2,227 incident HF events (incidence rate 10.3 per 1000 person-years). In fully adjusted models, the hazard ratios (95% confidence intervals) for HF comparing the 2 nd through 5 th quintiles of mtDNA-CN to the 1 st quintile were 0.91 (0.80–1.04), 0.82 (0.72–0.93), 0.81 (0.71–0.92), and 0.74 (0.65–0.85), respectively ( P for trend < 0.001). In stratified analyses, the associations between mtDNA-CN and HF were similar across examined subgroups. The inverse association between mtDNA-CN and incident HF was stronger in HF with reduced ejection fraction (HFrEF) than in HF with preserved ejection fraction (HFpEF). Conclusions In this prospective cohort, mtDNA-CN was inversely associated with the risk of incident HF suggesting that reduced levels of mtDNA-CN, a biomarker of mitochondrial dysfunction, could reflect early susceptibility to HF.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2019) conducted a cohort in Incident heart failure (n=10,802). Mitochondrial DNA copy number (mtDNA-CN) vs. Lowest quintile of mtDNA-CN was evaluated on Incident heart failure (first hospitalization for HF or death related to HF) (HR 0.74, 95% CI 0.65-0.85, p=<0.001). Higher mitochondrial DNA copy number was associated with a reduced risk of incident heart failure, with the highest quintile showing a 26% lower risk compared to the lowest quintile (HR 0.74).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: